Highpoint Pharmaceuticals LLC

Insider Reports History

Entity
Company
Location
16192 Coastal Highway, Lewes, DE
Signature
/s/ Sireesh Appajosyula
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Highpoint Pharmaceuticals LLC:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Hillstream BioPharma Inc. 10%+ Owner Common stock 972K $489K $0.50 Jan 11, 2022 Direct

Insider Reports Filed by Highpoint Pharmaceuticals LLC

Symbol Company Period Transactions Value $ Form Type Date Filed Role
HILS Hillstream BioPharma Inc. Jan 11, 2022 0 $0 3 Jan 11, 2022 10%+ Owner